Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
Canada
CaRe Clinics, Red Deer, Alberta Mount Saint Joseph Hospital Clinical Trials Phase 1 Unit, Vancouver, British Columbia Centricity Research, Toronto, Ontario Centricity Research, Toronto, Ontario Altasciences Company Inc., Mount Royal, Quebec Clinique RSF Inc., Québec, Quebec Diex Recherche Québec, Québec, Quebec Diex Recherche Sherbrooke, Sherbrooke, Quebec Diex Recherche Trois-Rivières, Trois-Rivières, Quebec Diex Recherche Victoriaville, Victoriaville, Quebec